MassIVE MSV000090171

Partial Public

Pseudomonas savastanoi pv phaseolicola R5 treated with resveratrol (proteomics)

Description

R5 was cultured in 10 mL Luria broth with 1.0 mM resveratrol or without (but with 50 uL DMSO) at 28 C at 200 rpm on a shaking platform until the cultures without resveratrol reached an average optical density (O.D.) of 0.78 (mid-log phase growth) at 600 nm. Protein was prepared by centrifuging the cultures at 5,000 x g, washing the cells two times in 5 mL phosphate buffered saline, resuspending the cells in 1 mL 100 mM Tris pH 8.5\1 mM EDTA\10 mM DTT\0.5% n-dodecyl beta-D-maltoside\Proteinase Inhibitor cOmplete [1 tablet/10 mL, Roche Diagnostics, Indianapolis, IN], and pulverizing the cells with 0.5 mm glass beads with a Qiagen PowerLyzer 24 bead mill (Qiagen, Hilden, Germany) 10 times at 5,000 rpm for 20 seconds (cooled on ice for 2 minutes between cycles). The extracts were centrifuged at 10,000 x g for 5 minutes, and the supernatants sent to the Thermo Fisher Scientific Center for Multiplexed Proteomics at the Harvard Medical School. Protein (~300 ug) was precipitated from the supernatants with methanol/chloroform, reduced in Tris(2-carboxyethyl)phosphine, carboxyamidomethylated with iodoacetamide, and digested sequentially with LysC and trypsin using methods previously described (Isasa et al., 2015). Peptides (~120 ug) were labeled with Tandem Mass Tags (TMTpro; Thermo Fisher Scientific) per the manufacturer instructions. Tags 126, 127N, and 127C were assigned to control replicates, and 128N, 128C and 129N were assigned to resveratrol-treated replicates. Samples were analyzed to determine tag label incorporation percentage (>95%) and to estimate quantitative ratios between samples. On the basis of the quantitative ratios, labeled samples were mixed together and fractionated by high-pH reverse phase HPLC (Isasa et al., 2015). Twelve concatenated fractions were analyzed. Peptides from each fraction were separated using a gradient of 3 to 22% of 90% acetonitrile\0.1% formic acid over 150 minutes and were electrosprayed at 2.6 kV into an Orbitrap Fusion Lumos mass spectrometer (Thermo Fisher Scientific) operating in data-dependent mode with positive polarity. Quadrupole isolation was enabled, and survey scans were recorded in the Orbitrap at 120,000 resolution over a mass range of 350-1500 m/z. The automatic gain control (AGC) target was set to 1,000,000 and the maximum injection time was set to 50 milliseconds (msec). The most abundant precursor ions (minimum intensity threshold 5,000) were fragmented by collision-induced dissociation (35% energy) and fragment ions were detected in the linear ion trap (AGC 15,000, 50 msec maximum injection). Analyzed precursors were dynamically excluded for 180 seconds. Multiple MS2 fragment ions were captured using isolation waveforms with multiple frequency notches and fragmented by high energy collision-induced dissociation (50% normalized collision energy). MS3 spectra were acquired in the Orbitrap (AGC 150,000; maximum injection time 200 msec, 50,000 resolution scanning from 100-1200 m/z). [doi:10.25345/C5BZ61C8R] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: resveratrol

Contact

Principal Investigators:
(in alphabetical order)
Bret Cooper, USDA-ARS, United States
Submitting User: cooperb
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

- Dataset Reanalyses


+ Dataset History


Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.